The patient's phenotype, rather than the variant of uncertain significance, supported withholding immunosuppression and using supportive therapy.
The FDA’s Office of Prescription Drug Promotion sent Travere Therapeutics a letter over its advertising for Filspari, a drug that’s approved to slow kidney function decline in people with primary IgA ...
Finerenone has shown positive therapeutic effects in diabetic kidney disease, but its role in hereditary podocytopathies such as hereditary FSGS has not been fully explored.
The "Focal Segmental Glomerulosclerosis - Market Insight, Epidemiology, Forecast - 2036" has been added to ResearchAndMarkets.com's offering. The report provides an in-depth assessment of FSGS ...
Most foamy urine is nothing to worry about but not all of it A urologist explains when its harmless when its not and what ...
Rituximab is associatied with numerically higher remission rates in lupus membranous nephritis, although 12-month renal response rates did not differ significantly across immunosuppressive strategies.
Resumo O que é: Formação de bolhas densas e persistentes no vaso sanitário, geradas por turbulência miccional, concentração ...